Home Print Stocks epaper Archives Company Info Edits & Columns

Make this your homepage | Feedback | RSS | Subscribe

Print Edition

Sections

Corporates & Markets

Supplement(s)

International Reports

FE@Campus

Ambani vs Ambani: RIL's affidavits

RNRL's submissions on the MoU

FE Centres

FE Columnists

Selections From The Economist

Cartoon Gallery

fe500 - India's Finest Companies

Events

FE Events

Services

Personal Loan-Citi Financial

Channels

Group Websites

FE Home- india inc - Story

BEYOND THE BOARDROOM : KIRAN MAJUMDAR SHAW Biocon’s Kiran Majumdar Shaw has not only broken

‘Gender issues disappear at a certain level’

Surabhi Agarwal
Posted: Thursday, Jan 03, 2008 at 0000 hrs IST
Updated: Thursday, Jan 03, 2008 at 0025 hrs IST

Font Size

Feedback

Discuss

: so many ambitious plans I have,” she goes on.

Fact File

* She studied brewing at University of Ballarat, Australia and started her career as trainee brewer in Carlton & United Beverages in 1974.

* She set up Biocon India in 1978 and the initial operation was to extract an enzyme from papaya.

* After Biocon’s IPO in 2004, she became the richest women in the country and Biocon was the only second Indian company to cross the $1-billion mark on the day of listing.

* Biocon is a healthcare company with a market capitalisation of Rs 58.28 billion that delivers biopharmaceutical solutions. ...

Post Comments

Comments: (Limit 3,000 characters)

Name		Message
Email ID
Subject

TERMS OF USE:
The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).

I agree to the terms of use.